戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 mmary gland development as a new category of peroxisomal disorders.
2 the pathogenesis of the two major classes of peroxisomal disorders.
3  prove to be useful in the diagnosis of some peroxisomal disorders.
4  for the study of pathogenetic mechanisms in peroxisomal disorders.
5 inked adrenoleukodystrophy (X-ALD) and other peroxisomal disorders.
6 e that mice with a PEX2 gene deletion have a peroxisomal disorder and provide an important model to s
7 s fatty acid accumulates in people with some peroxisomal disorders and is traditionally related to ne
8 igate heterozygotes, 797 patients with other peroxisomal disorders, and 29,600 control subjects.
9                                              Peroxisomal disorders are lethal inherited diseases caus
10                                              Peroxisomal disorders have been associated with malfunct
11                                Therapies for peroxisomal disorders have been unsatisfactory to date,
12                            The most frequent peroxisomal disorder is X-linked adrenoleukodystrophy, w
13 d adrenoleukodystrophy (X-ALD), an inherited peroxisomal disorder, is caused by mutations in the ABCD
14 kodystrophy, representing the other group of peroxisomal disorders, is caused by the lack of the adre
15  >C18:0) contribute to their toxic levels in peroxisomal disorders of fatty acid metabolism, such as
16        In 45 of 60 children with generalized peroxisomal disorders, we observed one or more intense i
17 cts from children diagnosed with generalized peroxisomal disorders were screened by continuous flow-n
18   X-linked adrenoleukodystrophy (X-ALD) is a peroxisomal disorder with impaired beta-oxidation of ver
19   X-linked adrenoleukodystrophy (X-ALD) is a peroxisomal disorder with impaired very-long-chain fatty
20 ctive in certain patients suffering from the peroxisomal disorder Zellweger syndrome, and with car1,

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。